Weinstein_James 10.25.2017
James Weinstein

Visiting Professor

Print Overview

Dr. James N. Weinstein is Chief Executive Officer and President of Dartmouth-Hitchcock Health. The $2 billion system includes New Hampshire's only academic medical center and a network of affiliated hospitals and clinics across Vermont and New Hampshire, serving a patient population of about 2 million. Under his leadership, Dartmouth-Hitchcock is working to create a "sustainable health system" for the patients and communities it serves, for generations to come. As leader of a bi-state health system, he has created an operating model based in population health and is transitioning the region from fee-for-service toward more global payments. He has built partnerships with a variety of providers throughout northern New England and the United States, to deliver optimum care at lowest cost to patients in the region.

Immediately prior to becoming CEO in 2011, Dr. Weinstein served as President of Dartmouth-Hitchcock Clinic and was Director of The Dartmouth Institute for Health Policy and Clinical Practice (TDI), home of the Dartmouth Atlas of Health Care, which for decades has documented the ongoing variations in health care delivery across the United States. His dual positions as Clinic President and TDI Director allowed him to build critical linkages between the groundbreaking health services research of TDI and the clinical care at Dartmouth-Hitchcock and nationally, with a focus on better understanding and meeting the population health needs of the region Dartmouth-Hitchcock serves and the nation.

During his time as Director of TDI, Dr. Weinstein co-founded, with then Dartmouth College President Jim Yong Kim (now President of the World Bank), the Master of Health Care Delivery Science (MHCDS) program, a collaboration between TDI and the Tuck School of Business, and the first hybrid residential and distance learning degree program at Dartmouth.

Dr. Weinstein is former Executive Director and a founding member, along with Mayo Clinic, Intermountain Healthcare, TDI, and Denver Health, of the national High Value Healthcare Collaborative (HVHC), a partnership of more than a dozen health systems that have taken on the challenge of improving the quality of care while lowering costs. The Collaborative allows for unprecedented data sharing, including electronic medical record data from each system, and the collection of patient reported measures, which Dr Weinstein started in the in 1982.

As a researcher and internationally renowned spine surgeon, Dr. Weinstein developed the classification system by which surgeons around the world treat cancers of the spine, as well as award-winning models for understanding pain mechanisms seen in millions of back pain patients. He has received more than $70 million in federal funding and has published more than 325 peer-reviewed articles. He is a leader in advancing "informed choice" to ensure patients receive evidence-based, safe, effective, efficient, and appropriate care. In 1999, he established the first-in-the-world Center for Shared Decision-Making at Dartmouth-Hitchcock, now used nationally and internationally. He also founded the multidisciplinary Spine Center at Dartmouth-Hitchcock, which has become an international model for patient-centered health care delivery and incorporates patient-reported outcomes in clinical practice, adding a new dimension to the process and clinical measurements traditionally used to judge the efficacy and value of care.  In 2015, Dr. Weinstein co-developed ImagineCare, a virtual health care system that incorporates 24/7 connectivity to manage chronic diseases outside the traditional bricks and mortar hospital based systems.

Most recently, he is helping to lead the formation of the Advanced Regenerative Manufacturing Institute (ARMI) which, with an $80 million grant from the Department of Defense and more than $300 million in private sector funding, will use 3D technology to print human organs, a development that could transform the world of organ transplantation and the lives of millions affected by diseases such as kidney disease and diabetes.

Dr. Weinstein holds the distinguished Peggy Y. Thomson Chair in the Evaluative Clinical Sciences at the Geisel School of Medicine at Dartmouth. He is a member of the National Academy of Medicine and serves on the organization's Board for Population Health and Public Health Practice. He serves as Chair of the NAM Committee on Community Based Solutions to Promote Health Equity in the U.S, which recently published the report, "Communities in Action: Pathways to Health Equity". He has recently been elected to the Board of Trustees for the internationally renowned Max Planck Florida Institute for Neuroscience.

Dr. Weinstein is an appointee to the Special Medical Advisory Group of the VA, which provides advice to the Secretary of Veterans Affairs and the Under Secretary for Health on matters relating to the care and treatment of veterans. He is frequently consulted by members of Congress and the Administration, as well as government leaders in New Hampshire and Vermont, on health policy and health reform.

In 2015, Dr. Weinstein was awarded the Ellis Island Medal of Honor by the National Ethnic Coalition of Organizations. He is the 2017 recipient of the American Hospital Association's Justin Ford Kimball Innovator's Award. He has been named one of "The 100 Most Influential People in Healthcare" by Modern Healthcare magazine and top "Physician Leaders to Know" by Becker's Hospital Review.

Dr. Weinstein recently announced his intention to step down from the position of CEO and President in June of 2017, so that he may focus more closely on national health care issues, particularly around innovation in health system design and care delivery. He also plans to continue his leadership roles in HVHC, ARMI, and other initiatives. His book, Unraveled: Prescriptions to Repair a Broken Health Care System, was published in February 2016.

Print Vita
Print Research

Print Teaching
Full-Time / Evening & Weekend MBA
Strategy and Execution for a Successful Healthcare Delivery System (HEMA-935-5)
Strategy is a core organizing theme in healthcare delivery science. This course will discuss the strategies, tactics and execution of health systems to provide population and value based care in new payment models. Strategy is essential for leadership and change management in determining what a health and healthcare delivery system should be doing or not doing in order to determine: where it’s going and how it intends to get there. The course is intended to help students recognize, develop, articulate, communicate and execute against said strategy with a limited set of measureable goals and objectives